LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

Search

LivaNova PLC

Open

54.85 -1.22

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

54.26

Max

55.65

Belangrijke statistieken

By Trading Economics

Inkomsten

354M

27M

Verkoop

36M

353M

K/W

Sectorgemiddelde

31.716

35.664

EPS

0.88

Winstmarge

7.705

Werknemers

2,900

EBITDA

340M

54M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+43.05% upside

Dividenden

By Dow Jones

Volgende Winsten

29 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

853M

3.2B

Vorige openingsprijs

56.07

Vorige sluitingsprijs

54.85

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

LivaNova PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 sep 2025, 22:39 UTC

Acquisities, Fusies, Overnames

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 sep 2025, 16:43 UTC

Belangrijke Marktbewegers

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 sep 2025, 16:42 UTC

Belangrijke Marktbewegers

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 sep 2025, 16:35 UTC

Belangrijke Marktbewegers

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 sep 2025, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 sep 2025, 23:46 UTC

Marktinformatie

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 sep 2025, 23:34 UTC

Marktinformatie

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 sep 2025, 22:48 UTC

Marktinformatie

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Expects Commercial Launch in 2029

15 sep 2025, 22:12 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 sep 2025, 22:11 UTC

Acquisities, Fusies, Overnames

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 sep 2025, 22:10 UTC

Acquisities, Fusies, Overnames

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 sep 2025, 21:16 UTC

Acquisities, Fusies, Overnames

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 sep 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 sep 2025, 21:14 UTC

Acquisities, Fusies, Overnames

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 sep 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

15 sep 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

15 sep 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

15 sep 2025, 19:29 UTC

Marktinformatie

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 sep 2025, 19:14 UTC

Marktinformatie

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 sep 2025, 18:16 UTC

Marktinformatie

Gold Powers to New High -- Market Talk

15 sep 2025, 18:05 UTC

Marktinformatie

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 sep 2025, 17:50 UTC

Acquisities, Fusies, Overnames

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 sep 2025, 17:10 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

15 sep 2025, 17:10 UTC

Marktinformatie

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 sep 2025, 16:52 UTC

Marktinformatie

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 sep 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

15 sep 2025, 16:20 UTC

Marktinformatie
Winsten

Auto & Transport Roundup: Market Talk

Peer Vergelijking

Prijswijziging

LivaNova PLC Prognose

Koersdoel

By TipRanks

43.05% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 79.29 USD  43.05%

Hoogste 168 USD

Laagste 58 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor LivaNova PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

6

Buy

1

Hold

0

Sell

Technische score

By Trading Central

36.34 / N/ASteun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over LivaNova PLC

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
help-icon Live chat